Analyst Price Targets — ASMB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 20, 2025 12:09 pm | Salim Syed | Mizuho Securities | $40.00 | $39.00 | TheFly | Assembly Biosciences price target raised to $40 from $29 at Mizuho |
| September 24, 2025 8:29 am | Roy Buchanan | JMP Securities | $38.00 | $25.90 | TheFly | Assembly Biosciences initiated with an Outperform at Citizens JMP |
| September 24, 2024 6:41 am | Salim Syed | Mizuho Securities | $36.00 | $16.26 | StreetInsider | Mizuho Reiterates Outperform Rating on Assembly Biosciences (ASMB) |
| September 20, 2024 3:30 am | Dennis Ding | Jefferies | $35.00 | $18.50 | StreetInsider | Jefferies Upgrades Assembly Biosciences (ASMB) to Buy |
Latest News for ASMB
Assembly Biosciences, Inc. (NASDAQ: ASMB - Get Free Report)'s stock price passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $29.48 and traded as high as $29.91. Assembly Biosciences shares last traded at $29.60, with a volume of 81,200 shares traded. Wall Street Analyst Weigh In
Assembly Biosciences, Inc. (NASDAQ: ASMB - Get Free Report)'s share price crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $28.97 and traded as high as $29.01. Assembly Biosciences shares last traded at $28.75, with a volume of 142,905 shares traded. Analyst Ratings Changes Several analysts
Parnell Pharmaceuticals (OTCMKTS:PARNF - Get Free Report) and Assembly Biosciences (NASDAQ: ASMB - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares Parnell Pharmaceuticals
Sol-Gel Technologies (NASDAQ: SLGL - Get Free Report) and Assembly Biosciences (NASDAQ: ASMB - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Valuation and Earnings This table compares Sol-Gel
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio's herpes simplex virus (HSV) helicase-primase inhibitor programs, including long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent genital herpes. These…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ASMB.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.